Low dose intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD) for the treatment of Paget's disease of bone (Q33557119)

28 July 2017

Low dose intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD) for the treatment of Paget's disease of bone (English)

1 reference

28 July 2017

Paget's disease of bone

1 reference

Cantrill JA

1

1 reference

28 July 2017

Buckler HM

series ordinal

2

1 reference

28 July 2017

Anderson DC

series ordinal

3

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 December 1986

1 reference

Annals of the Rheumatic Diseases

28 July 2017

1 reference

28 July 2017

45

1 reference

28 July 2017

12

1 reference

28 July 2017

1012-1018

1 reference

Clinical and biological effects of low doses of (3 amino-1 hydroxypropylidene)-1,1-bisphosphonate (APD) in Paget's disease of bone

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1002042

Side effects of disodium aminohydroxypropylidenediphosphonate (APD) during treatment of bone diseases.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1002042

Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1002042

Metabolism of disodium ethane-1-hydroxy-1,1-diphosphonate (disodium etidronate) in the rat, rabbit, dog and monkey

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1002042

Intestinal absorption of disodium ethane-1-hydroxy-1,1-diphosphonate (disodium etidronate) using a deconvolution technique.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1002042

Clinical experience with the use of two diphosphonates in the treatment of Paget's disease

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1002042

Absorption of oral diphosphonate in normal subjects

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1002042

Intravenous clodronate in the treatment and retreatment of Paget's disease of bone.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1002042

Diphosphonate Therapy of Paget's Disease of Bone

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1002042

Effects of disodium dichloromethylene diphosphonate on Paget's disease of bone

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1002042

Treatment of Paget's disease with (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.)

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1002042

Radiological demonstration of healing in Paget's disease of bone treated with APD

14 July 2018

1 reference

12 December 2020

Paget's Disease of the Bone: Observations After Cessation of Long-Term Synthetic Salmon Calcitonin Treatment

1 reference

12 December 2020

Paget's disease of bone: experiences with 100 patients treated with salmon calcitonin

1 reference

12 December 2020

Comparison of intravenous (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate and volume repletion in tumour-induced hypercalcaemia

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.45.12.1012

1 reference

28 July 2017

1 reference

28 July 2017

1 reference